Paper331107
Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study.
Murphy ML and 4 others. N Engl J Med, 1977. Cited by 444 papers, by iCite.
Cite this record
ConductScience Library. Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study. Papers, record 331107. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/331107
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angina Pectoris | Major topic |
| Coronary Artery Bypass | Major topic |
| Adult | |
| Aged | |
| Chronic Disease | |
| Evaluation Studies as Topic | |
| Humans | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Risk | |
| Saphenous Vein | |
| Transplantation, Autologous | |
| United States | |
| United States Department of Veterans Affairs |
Source PubMed
Cited by61
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 444 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38939019 | The Multidisciplinary Heart Team in Cardiovascular Medicine: Current Role and Future Challenges. | JACC Adv | 2023 | https://conductscience.org/library/papers/38939019 | PubMed |
| 37206527 | Effect of Gender on Postoperative Outcome and Duration of Ventilation After Coronary Artery Bypass Grafting (CABG). | Cureus | 2023 | https://conductscience.org/library/papers/37206527 | PubMed |
| 35629130 | An Individualized Approach of Multidisciplinary Heart Team for Myocardial Revascularization and Valvular Heart Disease-State of Art. | J Pers Med | 2022 | https://conductscience.org/library/papers/35629130 | PubMed |
| 35445696 | Long-term outcome of surgical revascularization in patients with reduced left ventricular ejection fraction-a population-based cohort study. | Interact Cardiovasc Thorac Surg | 2022 | https://conductscience.org/library/papers/35445696 | PubMed |
| 34977714 | Coronary surgery in women: How can we improve outcomes. | JTCVS Tech | 2021 | https://conductscience.org/library/papers/34977714 | PubMed |
| 34603514 | ISCHEMIA Trial: Key Questions and Answers. | Eur Cardiol | 2021 | https://conductscience.org/library/papers/34603514 | PubMed |
| 33734314 | Sex differences in acute cardiovascular care: a review and needs assessment. | Cardiovasc Res | 2022 | https://conductscience.org/library/papers/33734314 | PubMed |
| 32906673 | Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention. | J Clin Med | 2020 | https://conductscience.org/library/papers/32906673 | PubMed |
| 31969934 | Exploring Current Evidence on the Past, the Present, and the Future of the Heart Team: A Narrative Review. | Cardiovasc Ther | 2020 | https://conductscience.org/library/papers/31969934 | PubMed |
| 29605817 | Management of Left Main Coronary Artery Disease. | J Am Heart Assoc | 2018 | https://conductscience.org/library/papers/29605817 | PubMed |
| 25566709 | Efficacy of cardiac resynchronization with defibrillator insertion in patients undergone coronary artery bypass graft: a cohort study of cardiac function. | Ann Card Anaesth | 2015 | https://conductscience.org/library/papers/25566709 | PubMed |
| 22980305 | Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results. | Am Heart J | 2012 | https://conductscience.org/library/papers/22980305 | PubMed |
| 22638907 | Revascularization for left main and multivessel coronary artery disease in the drug-eluting stent era: integration of recent drug-eluting stent trials. | Curr Cardiol Rep | 2012 | https://conductscience.org/library/papers/22638907 | PubMed |
| 22555943 | Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature. | Curr Cardiol Rep | 2012 | https://conductscience.org/library/papers/22555943 | PubMed |
| 22269720 | Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. | Ann Thorac Surg | 2012 | https://conductscience.org/library/papers/22269720 | PubMed |
| 21146819 | "Topical" HDL for vein grafts: a new solution to an old problem? | Atherosclerosis | 2011 | https://conductscience.org/library/papers/21146819 | PubMed |
| 18748250 | Internal medicine-epitomes of progress: medical versus surgical treatment of coronary artery disease. | West J Med | 1978 | https://conductscience.org/library/papers/18748250 | PubMed |
| 18373326 | Trials and tribulations associated with angina and traditional therapeutic approaches. | Clin Cardiol | 2007 | https://conductscience.org/library/papers/18373326 | PubMed |
| 17174803 | Revascularize only for ischemia, especially if left ventricular function is poor. | J Nucl Cardiol | 2006 | https://conductscience.org/library/papers/17174803 | PubMed |
| 15886974 | Surgical ventricular restoration: the RESTORE Group experience. | Heart Fail Rev | 2004 | https://conductscience.org/library/papers/15886974 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/331107
GET https://conductscience.org/api/papers/v1/331107/cited_by?page=2